Tg Therapeutics Inc (TGTX)

Cost of Revenue

$141.00M

TTM · Period ending: · USD

TGTX logo

TGTX Cost of Revenue

Latest reported$141.00M
TGTX TTM Cost of Revenue ($0.00 → $141.00M)
High-resolution chart · PNG

TGTX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tg Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
141,001,000
118,745,000
100,776,000
78,033,000
59,219,000
48,585,000
38,567,000
31,114,000
25,282,000
18,889,000
14,223,000
6,280,000
2,773,000
885,000
265,000
472,000
762,000
887,000
789,000
685,000
393,000
245,000
106,000
169,055,000
169,055,000
169,055,000
169,055,000
0
0
0
0
0
0
0
0
78,969,128,000
78,969,128,000
78,969,128,000
78,969,128,000
0
0
0
0
55,721,092
55,721,092
55,721,092
55,721,092
22,965,989
22,965,989
22,965,989
22,965,989
26,895,099
26,895,099
26,895,099
26,895,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,257
15,257
15,257
15,257
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
295,316
2,350,941
3,725,941
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.